NRAS and melanoma: The TCGA network, employing whole exome sequence examination in patients diagnosed with local and/or advanced melanoma, recognized four unique genomic subtypes: those with mutations in NF1, mutations in BRAF, mutations in NRAS, and those categorized as triple wild type [56].